Hormones and Breast Cancer Risk in Women
Author Information
Author(s): HV Thomas, TJ Key, DS Allen, JW Moore, M Dowsett, IS Fentiman, DY Wang
Primary Institution: Imperial Cancer Research Fund
Hypothesis
Serum concentrations of oestradiol, testosterone, and luteal-phase progesterone are positively associated with risk of breast cancer, whereas serum sex hormone-binding globulin (SHBG) is negatively associated with risk.
Conclusion
The study suggests that while mean oestradiol concentration may be higher in women who develop breast cancer, the difference was not statistically significant.
Supporting Evidence
- The mean oestradiol concentration was 12% higher in cases than controls.
- Mid-cycle oestradiol concentration was 75% higher in cases compared to controls.
- None of the hormone concentration differences were statistically significant.
Takeaway
The study looked at hormone levels in women to see if they affect breast cancer risk, but found that the differences weren't strong enough to be sure.
Methodology
The study involved 62 breast cancer cases and 182 matched control subjects, measuring hormone levels through blood samples collected over several years.
Potential Biases
Potential biases include matching criteria and the influence of metabolic effects of early cancer on hormone levels.
Limitations
The study's findings may not be conclusive due to the small sample size and the non-significant differences in hormone levels.
Participant Demographics
Women aged 34 years and above from the island of Guernsey.
Statistical Information
P-Value
0.04 for mid-cycle oestradiol concentration
Confidence Interval
(0.87-2.63) for oestradiol odds ratio
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website